Trevi Therapeutics, Inc. (TRVI) › Net IncomeTrevi Therapeutics, Inc. (TRVI) — Net IncomeAnnual figures by fiscal year, from SEC filings.2018: -$20.55M2019: -$26.05M2020: -$32.76M2021: -$33.94M2022: -$29.15M2023: -$29.07M2024: -$47.91M2025: -$42.76M-$42.76M2018Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$42.76M+10.8%2024-$47.91M-64.8%2023-$29.07M+0.3%2022-$29.15M+14.1%2021-$33.94M-3.6%2020-$32.76M-25.8%2019-$26.05M-26.8%2018-$20.55M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share